Human albumin solutions, including hypo-oncotic (4%), iso-oncotic (5%), and hyper-oncotic (20–25%) formulations, are used to counteract hypoalbuminemia or for volume replacement [5,6,7]. Here, ALB is linked to Hypoalbuminemia.